DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,036 | -9.7% | 1,811 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $25,499 | -8.9% | 1,811 | 0.0% | 0.00% | -33.3% |
Q1 2023 | $27,980 | -5.7% | 1,811 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $29,682 | -12.7% | 1,811 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $34,000 | +41.7% | 1,811 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $24,000 | +41.2% | 1,811 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $17,000 | -5.6% | 1,811 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $18,000 | -71.0% | 1,811 | 0.0% | 0.00% | -66.7% |
Q3 2021 | $62,000 | -6.1% | 1,811 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $66,000 | -18.5% | 1,811 | 0.0% | 0.01% | -25.0% |
Q1 2021 | $81,000 | -21.4% | 1,811 | 0.0% | 0.01% | -27.3% |
Q4 2020 | $103,000 | +10.8% | 1,811 | 0.0% | 0.01% | -8.3% |
Q3 2020 | $93,000 | -13.9% | 1,811 | 0.0% | 0.01% | -20.0% |
Q2 2020 | $108,000 | +44.0% | 1,811 | 0.0% | 0.02% | +25.0% |
Q1 2020 | $75,000 | -33.6% | 1,811 | 0.0% | 0.01% | -20.0% |
Q4 2019 | $113,000 | +85.2% | 1,811 | 0.0% | 0.02% | +87.5% |
Q3 2019 | $61,000 | +48.8% | 1,811 | 0.0% | 0.01% | +33.3% |
Q2 2019 | $41,000 | -2.4% | 1,811 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $42,000 | +10.5% | 1,811 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $38,000 | -45.7% | 1,811 | 0.0% | 0.01% | -33.3% |
Q3 2018 | $70,000 | -1.4% | 1,811 | 0.0% | 0.01% | -10.0% |
Q2 2018 | $71,000 | – | 1,811 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |